Bayesian Capital Management’s Xilinx Inc XLNX Stock Holding History

Bayesian Capital Management’s Portfolio XLNX Stock Details XLNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,422	Closed	-$366K	–	561
2021 Q3	$366K	Buy	+2,422	New	+$355K	0.11%	228
2019 Q2	–	Sell	-36,396	Closed	-$4.62M	–	726
2019 Q1	$4.62M	Sell	36,396 -15,800	-30%	-$1.77M	0.89%	13
2018 Q4	$4.45M	Buy	52,196 +21,300	+69%	+$1.78M	0.91%	11
2018 Q3	$2.48M	Buy	30,896 +19,896	+181%	+$1.46M	0.41%	57
2018 Q2	$718K	Buy	+11,000	New	+$750K	0.16%	180
2017 Q4	–	Sell	-4,230	Closed	-$300K	–	776
2017 Q3	$300K	Sell	4,230 -14,970	-78%	-$978K	0.07%	365
2017 Q2	$1.24M	Buy	+19,200	New	+$1.21M	0.46%	47
2016 Q2	–	Sell	-16,106	Closed	-$764K	–	586
2016 Q1	$764K	Buy	+16,106	New	+$756K	0.72%	6

Other funds holding XLNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bayesian Capital Management's XLNX Position: Q4 2021 in Review

Bayesian Capital Management sold out of Xilinx Inc (XLNX) in Q4 2021, closing a stake of 2,422 shares — an estimated $366K sold.

Bayesian Capital Management first reported a position in XLNX in Q1 2016 and held it in 8 quarters. The position peaked at $4.62M in Q1 2019. 945 funds tracked by Wall St. Rank hold XLNX as of Q4 2021.

Bayesian Capital Management reported no remaining Xilinx Inc position as of Q4 2021 after selling out during the quarter.
Bayesian Capital Management sold 2,422 Xilinx Inc shares in Q4 2021, an estimated $366K.
Bayesian Capital Management first reported a position in Xilinx Inc in Q1 2016 and held it in 8 quarters.
Bayesian Capital Management's Xilinx Inc position peaked at $4.62M in Q1 2019.
945 funds tracked by Wall St. Rank held Xilinx Inc as of Q4 2021.

Based on Bayesian Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.